Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026

Get updates on Theralase Technologies Inc. delivered in your email.

Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > level 2

View:

Post by jicoop on Dec 06, 2021 9:48am

level 2

asks are starting to thin out already...

coop

Level 2 Quote

Level two quotes - Bid
Number of Shares		Bid Price
3,000 shares	3,000	0.365
46,000 shares	46,000	0.360
66,000 shares	66,000	0.355
65,500 shares	65,500	0.350
10,000 shares	10,000	0.345
15,000 shares	15,000	0.340
12,000 shares	12,000	0.335
34,000 shares	34,000	0.330
5,000 shares	5,000	0.320
14,000 shares	14,000	0.310

Level two quotes - Ask
Ask Price	Number of Shares
0.370	4,500	4,500 shares
0.375	3,000	3,000 shares
0.380	43,500	43,500 shares
0.385	8,000	8,000 shares
0.390	37,000	37,000 shares
0.395	55,500	55,500 shares
0.400	84,500	84,500 shares
0.405	47,000	47,000 shares
0.410	10,000	10,000 shares
0.420	20,000

607

Comment

Comment by DJDawg on Dec 06, 2021 9:50am

what is a good website to see this second level data (free)?

517

Comment

Theralase Technologies Inc.

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

Connect with V.TLT

INVESTORS & MEDIA OVERVIEW FINANCIAL FILINGS PRESENTATIONS MEDIA FACT SHEETS MANAGEMENT

Investor Presentation

The Road to Saving Lives: Clinical Study Underway

Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
Best-in-class treatment for NMIBC (according to interim clinical data)
NMIBC (Non-Muscle-Invasive Bladder Cancer)

FACT SHEET

The Watchlist

< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
Best-in-class treatment for NMIBC (according to interim clinical data)
NMIBC (Non-Muscle-Invasive Bladder Cancer)

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250

Become a member today, It's free!

Sign In

Send my password